Table 2. Baseline data with neuroendocrine differentiation.
Factor | Case | ||||
---|---|---|---|---|---|
Total | NED | Non-NED | X2 | P | |
All patients | 82 | 15 | 67 | ||
Sex | 0.006 | 0.939 | |||
Male | 43 | 8 | 35 | ||
Female | 39 | 7 | 32 | ||
Age | 0.006 | 1.000 | |||
<50 | 17 | 3 | 14 | ||
>50 | 65 | 12 | 53 | ||
Tumor Site | 0.221 | 0.765 | |||
Colon | 56 | 11 | 45 | ||
Rectum | 26 | 4 | 22 | ||
Tumor Differentiation | 0.111 | 0.946 | |||
High | 31 | 6 | 25 | ||
Moderate | 32 | 6 | 26 | ||
Low | 19 | 3 | 16 | ||
TNM Stage | 2.999 | 0.392 | |||
I | 6 | 0 | 6 | ||
II | 28 | 6 | 22 | ||
III | 36 | 6 | 30 | ||
IV | 12 | 3 | 9 | ||
Lymphatic metastasis | 0.106 | 0.899 | |||
Positive | 48 | 9 | 39 | ||
Negative | 34 | 6 | 28 | ||
Distant Metastasis | 7.16 | 0.007 | |||
Yes | 30 | 10 | 20 | ||
No | 52 | 5 | 47 |